Reducing Hereditary Cancer Act
Sponsored By: Representative Wasserman Schultz
Introduced
Summary
Expands Medicare coverage for hereditary cancer genetic testing and related preventive care. It would let Medicare cover germline mutation testing, repeat tests, guideline-based risk-reducing surgeries, and more frequent high-risk screenings for people with personal or family histories that suggest hereditary cancer.
Show full summary
- Patients with a personal or family history suspicious for hereditary cancer would be eligible for Medicare-covered germline mutation testing that follows evidence-based clinical practice guidelines. Repeat testing would also be allowed when appropriate.
- People with identified hereditary cancer mutations would have guideline-recommended risk-reducing surgeries covered as medically necessary under Medicare.
- Individuals identified at high genetic risk would qualify for more frequent evidence-based screenings such as screening mammography, breast MRI, colonoscopy, and PSA testing, with coverage aligned to guidelines and at least annually.
- National oncology organizations, including the National Comprehensive Cancer Network, the American Society of Clinical Oncology, and the Society of Gynecologic Oncology would guide testing and screening standards, and Medicare contractors may adopt the least restrictive guideline when recommendations conflict.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
More Medicare coverage for hereditary cancer
Medicare would cover genetic tests for inherited cancer if your or your family's history suggests it, including repeat tests. Tests and care must follow evidence-based guidelines from major oncology groups, using the least restrictive standard if guidelines conflict. If testing shows an inherited cancer gene, Medicare would cover risk-reducing surgery when guidelines recommend it. It would also cover screenings at least yearly, including mammograms, breast MRI, colonoscopy, and PSA tests. Changes would start for services after enactment.
Sponsors & CoSponsors
Sponsor
Wasserman Schultz
FL • D
Cosponsors
Miller-Meeks
IA • R
Sponsored 7/23/2025
Schrier
WA • D
Sponsored 7/23/2025
Buchanan
FL • R
Sponsored 7/23/2025
Cohen
TN • D
Sponsored 8/8/2025
Dingell
MI • D
Sponsored 8/8/2025
Gottheimer
NJ • D
Sponsored 8/8/2025
Simon
CA • D
Sponsored 8/8/2025
Carson
IN • D
Sponsored 8/8/2025
Del. Norton, Eleanor Holmes [D-DC-At Large]
DC • D
Sponsored 8/15/2025
Bonamici
OR • D
Sponsored 8/19/2025
Cisneros
CA • D
Sponsored 10/10/2025
Nunn (IA)
IA • R
Sponsored 11/7/2025
McBride
DE • D
Sponsored 12/9/2025
Fitzpatrick
PA • R
Sponsored 2/9/2026
Kennedy (NY)
NY • D
Sponsored 2/9/2026
Tonko
NY • D
Sponsored 2/9/2026
Goldman (NY)
NY • D
Sponsored 2/9/2026
Bacon
NE • R
Sponsored 2/13/2026
Matsui
CA • D
Sponsored 2/13/2026
Dean (PA)
PA • D
Sponsored 3/19/2026
Hayes
CT • D
Sponsored 3/19/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in